AAAAAA

   
Results: 1-25 | 26-35 |
Results: 26-35/35

Authors: Press, OW Eary, JF Gooley, T Gopal, AK Liu, S Rajendran, JG Maloney, DG Petersdorf, S Bush, SA Durack, LD Martin, PJ Fisher, DR Wood, B Borrow, JW Porter, B Smith, JP Matthews, DC Appelbaum, FR Bernstein, ID
Citation: Ow. Press et al., A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas, BLOOD, 96(9), 2000, pp. 2934-2942

Authors: Mathioudakis, G Storb, R McSweeney, PA Torok-Storb, B Lansdorp, PM Brummendorf, TH Gass, MJ Bryant, EM Storek, J Flowers, MED Gooley, T Nash, RA
Citation: G. Mathioudakis et al., Polyclonal hematopoiesis with variable telomere shortening in human long-term allogeneic marrow graft recipients, BLOOD, 96(12), 2000, pp. 3991-3994

Authors: Lin, MT Tseng, LH Frangoul, H Gooley, T Pei, J Barsoukov, A Akatsuka, Y Hansen, JA
Citation: Mt. Lin et al., Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation, BLOOD, 95(12), 2000, pp. 3832-3839

Authors: Georges, GE Storb, R Thompson, JD Yu, C Gooley, T Bruno, B Nash, RA
Citation: Ge. Georges et al., Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation, BLOOD, 95(10), 2000, pp. 3262-3269

Authors: Shulman, HM Wells, D Gooley, T Myerson, D Bryant, E Loken, MR
Citation: Hm. Shulman et al., The biologic significance of rare peripheral blasts after hematopoietic cell transplantation is predicted by multidimensional flow cytometry, AM J CLIN P, 112(4), 1999, pp. 513-523

Authors: Boeckh, M Gooley, T Leisenring, W Myerson, D Corey, L
Citation: M. Boeckh et al., Does high-dose prophylactic acyclovir add benefit in allogeneic marrow transplant recipients receiving prophylactic or preemptive ganciclovir? Reply, J INFEC DIS, 180(2), 1999, pp. 572-574

Authors: Tseng, LH Lin, MT Hansen, JA Gooley, T Pei, J Smith, AG Martin, EG Petersdorf, EW Martin, PJ
Citation: Lh. Tseng et al., Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation, BLOOD, 94(8), 1999, pp. 2911-2914

Authors: Martin, PJ Rowley, SD Anasetti, C Chauncey, TR Gooley, T Petersdorf, EW van Burik, J Flowers, MED Storb, R Appelbaum, FR Hansen, JA
Citation: Pj. Martin et al., A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients, BLOOD, 94(7), 1999, pp. 2192-2199

Authors: Boeckh, M Bowden, RA Gooley, T Myerson, D Corey, L
Citation: M. Boeckh et al., Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients, BLOOD, 93(5), 1999, pp. 1781-1782

Authors: Gibbs, JP Gooley, T Corneau, B Murray, G Stewart, P Appelbaum, FR Slattery, JT
Citation: Jp. Gibbs et al., The impact of obesity and disease on busulfan oral clearance in adults, BLOOD, 93(12), 1999, pp. 4436-4440
Risultati: 1-25 | 26-35 |